1252672-36-8

Basic information

• Product Name: 4-(benzyloxycarbonylamino)bicyclo[2.2.1]heptane-1-carboxylic acid
• Synonyms: 4-(benzyloxycarbonylamino)bicyclo[2.2.1]heptane-1-carboxylic acid
• CAS NO: 1252672-36-8
• Molecular Weight: 289.331
• Mol File: 1252672-36-8.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 4-(benzyloxycarbonylamino)bicyclo[2.2.1]heptane-1-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(benzyloxycarbonylamino)bicyclo[2.2.1]heptane-1-carboxylic acid(1252672-36-8)
• EPA Substance Registry System: 4-(benzyloxycarbonylamino)bicyclo[2.2.1]heptane-1-carboxylic acid(1252672-36-8)

Safety Data

• Hazardous Substances Data: 1252672-36-8(Hazardous Substances Data)

Upstream product

• 4056-78-4 cyclopentane-1,3-dicarboxylic acid 
• 498-66-8 norborn-2-ene 
• 15448-77-8 4-carbomethoxybicyclo<2.2.1>heptane-1-carboxylic acid 
• 100-51-6 benzyl alcohol 
• 2435-36-1 cyclopentane?1,3?dimethyl formate 
• 15448-76-7 dimethyl bicyclo<2.2.1>heptane-1,4-dicarboxylate 
• 1252672-35-7 4-(benzyloxycarbonylamino)bicyclo[2.2.1]heptane-1-carboxylic acid methyl ester 

Downstream Products

• 737693-57-1 4-aminobicyclo[2.2.1]heptane-1-carboxylic acid 
• 1403865-38-2 benzyl 4-hydroxybicyclo[2.2.1]heptan-1-ylcarbamate 
• 1252672-37-9 4-carbamoylbicyclo[2.2.1]hept-1-ylcarbamic acid benzyl ester 

Relevant articles and documents

Aminonorbornane derivative and preparation method and application thereof

The invention discloses an aminonorbornane derivative and a preparation method and application thereof and relates to a compound having a structure represented by a formula I which is described in thespecification or a pharmaceutically acceptable salt, a solvate, an active metabolite, a polymorph, an ester, an optical isomer or a prodrug thereof, a pharmaceutical composition comprising the compound as shown in the formula I, and application of the compound and the pharmaceutical composition as highly selective Bruton's tyrosine kinase (BTK) inhibitors of BTK (C481S) mutants for preparation ofdrugs used for prevention or treatment of heteroimmune diseases, autoimmune diseases or cancer.

NOVEL AMIDE AND AMIDINE DERIVATIVES AND USES THEREOF

The present invention relates to inhibitors of 11-β-hydroxysteroid dehydrogenase type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids.